Feb 4, 2009 - Wedgewood Pharmacy will continue to compound 17-AlphaHydroxyprogesterone Caproate (17P) following the Federal Drug Administration's (FDA) January 26 rejection of KV Pharmaceutical Co.'s application to seek New Drug Approval for the substance.
The details can be read here.
No comments:
Post a Comment